NCT07214285View on ClinicalTrials.gov

Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopamine (Anaerobic Dopamine)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2025

Conditions
Parkinson Disease
Interventions
DRUG

A-DOPAMINE

Intracerebral infusion of anaerobic dopamine.

DEVICE

A-DOPAMINE

Intracerebral infusion of anaerobic dopamine with pump device.

Trial Locations (1)

59000

RECRUITING

UHLillle, Lille

Sponsors

Collaborators (1)

InBrain Pharma
All Listed Sponsors
collaborator

InBrain Pharma

UNKNOWN

lead

University Hospital, Lille

OTHER